反应详情

The title compound was prepared in a manner analogous to Example 19, substituting (1R,6S)-2-(3,8-diaza-bicyclo[4.2.0]oct-8-yl)-quinoxaline (Intermediate 3) for 8-(4-phenyl-pyrimidin-2-yl)-3,8-diaza-bicyclo[4.2.0]octane and 2,4-dimethyl-benzenesulfonyl chloride for 2,5-dimethyl-benzenesulfonyl chloride. MS (ESI) mass calcd. for C22H24N4O2S, 408.52; m/z found 409.2 [M+H]+. 1H NMR (400 MHz, CDCl3): 7.96 (s, 1H), 7.86 (dd, J=8.2, 1.3, 1H), 7.66 (d, J=1.2, 1H), 7.58-7.52 (m, 1H), 7.49 (dd, J=8.4, 1.1, 1H), 7.43-7.37 (m, 1H), 6.62-6.48 (m, 2H), 4.69-4.61 (m, 1H), 4.22-3.95 (m, 4H), 3.85-3.74 (m, 1H), 3.69-3.59 (m, 1H), 3.41 (dd, J=14.0, 2.8, 1H), 3.05-2.89 (m, 1H), 2.42 (s, 3H), 2.30-2.14 (m, 1H), 2.09 (s, 3H), 2.05-1.92 (m, 1H).